Antibiotics : targets, mechanisms and resistance /

Λεπτομέρειες βιβλιογραφικής εγγραφής
Άλλοι συγγραφείς: Gualerzi, Claudio O., 1942-
Μορφή: Ηλ. βιβλίο
Γλώσσα:English
Έκδοση: Weinheim, Germany : Wiley-VCH, [2014]
Θέματα:
Διαθέσιμο Online:Full Text via HEAL-Link
LEADER 03643nam a2200601 4500
001 ocn858657953
003 OCoLC
005 20170124071835.8
006 m o d
007 cr |n|||||||||
008 130920s2014 gw a ob 001 0 eng d
040 |a IDEBK  |b eng  |e pn  |c IDEBK  |d OCLCQ  |d E7B  |d DG1  |d CUS  |d YDXCP  |d DEBBG  |d OCLCF  |d UBY  |d NLGGC  |d OCLCQ  |d COO  |d OCLCQ  |d GrThAP 
020 |a 9783527659685  |q (electronic bk.) 
020 |a 3527659684  |q (electronic bk.) 
020 |a 1299854656  |q (ebk) 
020 |a 9781299854659  |q (ebk) 
020 |a 9783527659715  |q (e-book) 
020 |a 3527659714  |q (e-book) 
020 |a 9783527333059  |q (hbk.) 
020 |a 3527333053  |q (hbk.) 
029 1 |a AU@  |b 000052185441 
029 1 |a CHBIS  |b 010131729 
029 1 |a CHVBK  |b 314712992 
029 1 |a DEBBG  |b BV041407601 
029 1 |a GBVCP  |b 79020990X 
029 1 |a NZ1  |b 15497579 
029 1 |a NZ1  |b 15697421 
029 1 |a NZ1  |b 15905608 
035 |a (OCoLC)858657953 
037 |a 516716  |b MIL 
050 4 |a RM267 
082 0 4 |a 615.7/922  |2 23 
049 |a MAIN 
245 0 0 |a Antibiotics :  |b targets, mechanisms and resistance /  |c edited by Claudio O. Gualerzi [and others]. 
264 1 |a Weinheim, Germany :  |b Wiley-VCH,  |c [2014] 
264 4 |c ©2014 
300 |a 1 online resource (xxiv, 549 pages) :  |b illustrations (some color) 
336 |a text  |b txt  |2 rdacontent 
337 |a computer  |b c  |2 rdamedia 
338 |a online resource  |b cr  |2 rdacarrier 
504 |a Includes bibliographical references and index. 
588 0 |a Online resource; title from PDF title page (Wiley, viewed November 4, 2013). 
505 0 |a A chemist's survey of different antibiotic classes -- Antibacterial discovery: problems and possibilities -- Impact of microbial natural products on antibacterial drug discovery -- Antibiotics and resistance: a fatal attraction -- Fitness costs of antibiotic resistance -- Inhibitors of cell-wall synthesis -- Inhibitors of bacetrial cell partitioning -- The membrane as a novel target site for antibiotics to kill persisting bacterial pathogens -- Bacterial membrane, a key for controlling drug influx and efflux -- Interference with bacterial cell-to-cell chemical signaling in development of new anti-infectives -- Recent developments in inhibitors of bacterial type IIA topoisomerases -- Antibiotics targeting bacterial RNA polymerase -- Inhibitors targeting riboswitches and ribozymes -- Targeting ribonuclease P -- Involvement of ribosome biogenesis in antibiotic functions, acquired resistance, and future opportunities in drug discovery -- Aminoacyl-tRNA synthetase inhibitors -- Antibiotics targeting translation initiation in prokaryotes -- Inhibitors of bacterial elongation factor EF-Tu -- Aminoglycoside antibiotics: structural decoding of inhibitors targeting the ribosomal decoding A site -- Reptidyltransferase inhibitors of the bacterial ribosome -- Antibiotics inhibiting the translocation step of protein elongation on the ribosome -- Antibiotics at the ribosomal exit tunnel -- selected structual aspects -- Targeting HSP70 to fight cancer and bad bugs: one and the same battle? 
650 0 |a Antibiotics. 
650 0 |a Antibiotics  |x Physiological effect. 
650 2 |a Anti-Bacterial Agents. 
650 7 |a Antibiotics.  |2 fast  |0 (OCoLC)fst00810420 
650 7 |a Antibiotics  |x Physiological effect.  |2 fast  |0 (OCoLC)fst00810431 
655 4 |a Electronic books. 
700 1 |a Gualerzi, Claudio O.,  |d 1942- 
776 0 8 |i Print version:  |t Antibiotics.  |d Weinheim : Wiley-VCH, 2013  |z 9783527333059  |w (OCoLC)856201915 
856 4 0 |u https://doi.org/10.1002/9783527659685  |z Full Text via HEAL-Link 
994 |a 92  |b DG1